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Davies et al use data from a cohort of chlamydia tested and never-chlamydia tested women 
constructed from the Danish registry study to estimate the risk of reproductive complications1. The 
analyses show associations between chlamydia testing (positive, negative, untested) and 
reproductive outcomes over the subsequent 15 years. However, the paper and an accompanying 
editorial seriously over-interpret the data.  
Loose language crosses the line between causation and association. For example, statements like “a 
positive chlamydia test increased the risk… by at least 30%”, ”a single diagnosed infection increases 
the risk…” or “… a repeat diagnosis increases the risk ….” strongly imply causality. The design is 
similar to the earlier Uppsala study2.  A CDC expert group3 identified a series of methodological 
difficulties with studies of this type, among them the already insurmountable problem that women 
testing positive were treated.  It is simply not possible to derive meaningful, causal estimates from 
studies of this type, and the editorialist’s assertion that the paper “quantified the risk of 
reproductive complications attributable to chlamydia infection” is incorrect. 
As the study gives no evidence that the single or repeat events of CT diagnosis (positive or negative) 
cause an increase in the risk of complications, it cannot substantiate claims that interrupting this will 
be effective. So although the conclusion that “control programs must prevent first and repeat 
infections to improve women’s reproductive health” could be correct, this study adds no relevant 
information to support it, nor to the editorialist’s recommendation of “a more intensive approach 
than test and treat”.  
We recently published estimates of the risks of reproductive damage attributable to chlamydia4 in 
the UK. Central estimates are that every 1,000 CT infections in women on average cause 170 
episodes of PID, 70 of salpingitis, 2 ectopic pregnancies (EP) and 5 of Tubal Factor Infertility (TFI). 
These estimates, which include undiagnosed chlamydia, PID and salpingitis, were based on estimates 
of chlamydia incidence, prevalence and duration in the UK, an estimate of the risk of PID following 
CT infection based on randomized evidence, and many other sources of systematically identified 
evidence. These estimates were constructed in a way that makes them internally coherent and 
consistent with data on the incidence of PID, EP and TFI in the UK. 
Finite mixture modeling of serology data may be another route towards estimating the proportion of 
reproductive damage attributable to chlamydia5, but this needs further validation. 
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